Besides, EZH2 has been reported to activate signaling pathways associated with the maintenance of lung cancer stem cells, while inhibition of EZH2 could enhance the sensitivity of lung cancer toward chemotherapy (Hussain et al., 2009; Fillmore et al., 2015). Here, EZH2 is linked to lung carcinoma.